NYSE International 100

NYSE International 100 handeln
10.756,79 PKT +273,65 PKT +2,61 %
finanzen.net zero
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

Analysen zu NYSE International 100-Werten

Datum Rating Analyst
20.03.20 Siemens buy Jefferies & Company Inc.
19.03.20 Sanofi buy Goldman Sachs Group Inc.
19.03.20 BP overweight Barclays Capital
19.03.20 Eni Underweight Barclays Capital
19.03.20 Shell (ex Royal Dutch Shell) Equal weight Barclays Capital
19.03.20 Shell (ex Royal Dutch Shell) Equal weight Barclays Capital
19.03.20 TotalEnergies overweight Barclays Capital
19.03.20 Eni buy UBS AG
19.03.20 TotalEnergies buy Kepler Cheuvreux
19.03.20 Eni buy Kepler Cheuvreux
19.03.20 BP buy Kepler Cheuvreux
19.03.20 BT Group buy Jefferies & Company Inc.
19.03.20 Orange buy Jefferies & Company Inc.
19.03.20 Telefonica buy Jefferies & Company Inc.
19.03.20 Vodafone Group buy Jefferies & Company Inc.
19.03.20 Rio Tinto buy Jefferies & Company Inc.
19.03.20 ABB (Asea Brown Boveri) Sector Perform RBC Capital Markets
19.03.20 Eni Underperform RBC Capital Markets
19.03.20 UBS Sector Perform RBC Capital Markets
19.03.20 ABB (Asea Brown Boveri) buy UBS AG
19.03.20 Siemens buy UBS AG
19.03.20 National Grid buy HSBC
19.03.20 Deutsche Telekom Hold Jefferies & Company Inc.
19.03.20 Siemens Outperform RBC Capital Markets
18.03.20 SAP kaufen DZ BANK
18.03.20 Mercedes-Benz Group (ex Daimler) Sell Goldman Sachs Group Inc.
18.03.20 Deutsche Telekom Underweight Barclays Capital
18.03.20 Vodafone Group overweight Barclays Capital
18.03.20 Telefonica kaufen Barclays Capital
18.03.20 Sanofi Outperform Bernstein Research
18.03.20 Unilever buy Jefferies & Company Inc.
18.03.20 Unilever buy Jefferies & Company Inc.
17.03.20 Allianz kaufen DZ BANK
17.03.20 Deutsche Telekom buy HSBC
17.03.20 Telefonica Neutral Goldman Sachs Group Inc.
17.03.20 Diageo Underweight JP Morgan Chase & Co.
17.03.20 Novartis Underweight Barclays Capital
17.03.20 GSK Underweight Barclays Capital
17.03.20 AstraZeneca overweight Barclays Capital
17.03.20 UBS Sector Perform RBC Capital Markets